Exact Sciences Corporatio...

AI Score

0
XX

Unlock

54.26
-4.25 (-7.26%)
At close: Jan 14, 2025, 3:59 PM
54.56
0.55%
After-hours Jan 14, 2025, 07:59 PM EST

Exact Sciences Corporation Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020
COVID-19 Testing Revenue 0 0 0 5.96M 0 2.13M 3.82M 6.04M 10.87M 13.75M 27.43M 47.10M 30.59M 33.07M 32.34M 99.09M 102.16M 34.58M
COVID-19 Testing Revenue Growth n/a n/a -100.00% n/a -100.00% -44.23% -36.67% -44.47% -20.94% -49.87% -41.76% +53.97% -7.51% +2.26% -67.36% -3.01% +195.44% n/a

Revenue by Geography

Quarter Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Non-Us Revenue 117.74M 109.91M 77.48M 11.44M
Non-Us Revenue Growth +7.12% +41.85% +577.07% n/a
United States Revenue 1.97B 1.66B 1.41B 864.85M
United States Revenue Growth +18.67% +17.21% +63.49% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 411.90M 387.13M 435.50M 411.03M 390.55M 414.45M 404.26M 404.11M 379.70M 397.60M 401.98M 463.67M 383.12M 362.43M 453.84M 312.28M 252.08M 225.55M 281.75M 264.26M 166.80M 151.92M 154.97M 133.21M 111.54M 94.03M 88.97M 74.37M 68.57M 61.33M 58.90M 52.00M 46.61M 47.60M 43.51M 37.81M 38.51M 34.28M 28.72M
Selling, General, and Administrative Revenue Growth +6.40% -11.11% +5.95% +5.24% -5.77% +2.52% +0.04% +6.43% -4.50% -1.09% -13.30% +21.03% +5.71% -20.14% +45.33% +23.88% +11.76% -19.95% +6.62% +58.44% +9.79% -1.96% +16.34% +19.43% +18.62% +5.68% +19.64% +8.46% +11.81% +4.12% +13.26% +11.58% -2.09% +9.40% +15.08% -1.83% +12.36% +19.33% n/a
Research and Development Revenue 100.10M 120.88M 110.61M 114.92M 111.45M 104.09M 95.42M 94.27M 90.81M 106.08M 102.25M 88.49M 75.36M 106.23M 115.57M 446.40M 31.47M 32.67M 43.51M 43.22M 34.95M 30.20M 32.02M 20.93M 17.63M 14.71M 14.94M 12.68M 11.72M 9.74M 8.00M 7.08M 7.63M 8.64M 10.13M 9.37M 9.86M 8.12M 6.57M
Research and Development Revenue Growth -17.19% +9.29% -3.75% +3.12% +7.06% +9.09% +1.21% +3.81% -14.39% +3.75% +15.55% +17.43% -29.07% -8.07% -74.11% +1318.45% -3.68% -24.91% +0.66% +23.69% +15.70% -5.66% +52.95% +18.72% +19.84% -1.49% +17.83% +8.10% +20.42% +21.68% +12.99% -7.12% -11.75% -14.68% +8.13% -5.05% +21.54% +23.50% n/a
Sales and Marketing Revenue 194.65M 51.80M 50.40M 57.59M 173.16M 176.49M 186.96M 210.21M 66.00M 72.80M 232.18M 284.30M 196.62M 194.83M 186.14M 166.83M 136.48M 118.86M 167.75M 119.85M 86.20M 88.19M 90.94M 76.77M 64.84M 54.43M 53.41M 40.63M 37.77M 36.73M 38.80M 30.51M 26.31M 30.30M 25.71M 21.94M 23.08M 20.59M 16.52M
Sales and Marketing Revenue Growth +275.78% +2.78% -12.48% -66.74% -1.89% -5.60% -11.06% +218.50% -9.34% -68.65% -18.33% +44.60% +0.92% +4.67% +11.58% +22.23% +14.82% -29.14% +39.96% +39.04% -2.26% -3.02% +18.45% +18.41% +19.12% +1.92% +31.46% +7.57% +2.83% -5.34% +27.19% +15.96% -13.18% +17.85% +17.17% -4.92% +12.07% +24.62% n/a

Create Price Alert on EXAS

Your price alert will notify you when the stock price is above 54.26.

Add to Watchlist